Timothy Block

Develops drug therapy for treatment of chronic liver diseases

The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education, advocacy, and patient support. The non-profit company is based in Doylestown, PA. The foundation provides educational resources on hepatitis B prevention, diagnosis, treatment, and management, emphasizing vaccination, testing, and early intervention. It addresses special populations such as children and individuals coinfected with HIV, offers expert guidelines and support programs, combats stigma and discrimination, and advocates for patients’ rights. The foundation supports patients and healthcare providers with clinical trial information, physician directories, medication assistance, online support groups, and training programs. The company was founded by Joan M. Block, Timothy M. Block. Louis P. Kassa has been the CEO of the company since 2022.

Functions as a College/University

Operates as a non-profit research organization

The Baruch S. Blumberg Institute is a nonprofit translational research organization dedicated to curing hepatitis B and liver cancer. The non-profit company is based in Doylestown, PA. The institute conducts multidisciplinary research in virology, antiviral drug discovery, biopharmaceutics (including RNA and gene-editing therapeutics), precision medicine, cancer and regenerative medicine, and public health focused on eliminating health disparities related to hepatitis B. It operates within a collaborative ecosystem alongside the Hepatitis B Foundation and the Pennsylvania Biotechnology Center, and manages B+Labs, which provides wet lab and office space to support innovation and entrepreneurship in life sciences. The institute offers training programs such as summer internships, high school science enrichment, AP chemistry mentorships, and post-graduate education, and hosts a seminar series to promote scientific exchange and collaboration. It partners with academic institutions and patient communities to integrate research, education, and advocacy, and is supported by donor contributions to advance research, education, and public health efforts for hepatitis B, liver cancer, and related viral diseases. The company was founded by Timothy M. Block.

Develops unique and non-invasive blood tests for liver cancers and fibrosis-cirrhosis

Hatch Biofund Management invests in companies located in the United States. The firm focuses on the biotechnology sectors. it participates in the early stage capital requirements.